Remedium Lifecare [REMLIFE] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Remedium Lifecare Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Remedium Lifecare Ltd. wins in 13 metrics, Sun Pharma Advanced Research Company Ltd. wins in 5 metrics, with 0 ties. Remedium Lifecare Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Remedium Lifecare Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 6.54 -13.65 Remedium Lifecare Ltd.
Price-to-Book Ratio 0.71 -13.55 Remedium Lifecare Ltd.
Debt-to-Equity Ratio 1,033.81 -1.21 Remedium Lifecare Ltd.
PEG Ratio 0.03 -11.15 Remedium Lifecare Ltd.
EV/EBITDA 206.57 -22.27 Remedium Lifecare Ltd.
Profit Margin (TTM) 2.33% -53.22% Remedium Lifecare Ltd.
Operating Margin (TTM) 6.64% -700.71% Remedium Lifecare Ltd.
EBITDA Margin (TTM) 6.64% N/A N/A
Return on Equity 16.22% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 0.19% -102.08% Remedium Lifecare Ltd.
Free Cash Flow (TTM) $-11.44B $-3.71B Sun Pharma Advanced Research Company Ltd.
1-Year Return -78.03% 14.56% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 0.14 87.98 Remedium Lifecare Ltd.
Enterprise Value $11.62B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 2.21 95.73 Remedium Lifecare Ltd.
Gross Profit Margin (TTM) 9.53% -59.53% Remedium Lifecare Ltd.
Revenue per Share (TTM) $8 $2 Remedium Lifecare Ltd.
Earnings per Share (Diluted) $0.13 $-8.25 Remedium Lifecare Ltd.
Beta (Stock Volatility) 1.04 0.19 Sun Pharma Advanced Research Company Ltd.

Remedium Lifecare Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

REMLIFE
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Remedium Lifecare Ltd.-2.78%-5.41%-20.45%-30.00%-65.35%-53.33%
Sun Pharma Advanced Research Company Ltd.-0.07%-3.79%52.45%72.49%40.02%57.72%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Remedium Lifecare Ltd.-78.03%-97.95%-55.81%245.45%245.45%245.45%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Remedium Lifecare Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricREMLIFESPARC
Market Information
Market Cap i₹308.70M₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i13,880,4892,401,062
90 Day Avg. Volume i13,121,8132,083,443
Last Close₹0.35₹212.82
52 Week Range₹0.32 - ₹1.80₹108.00 - ₹248.75
% from 52W High-80.56%-14.44%
All-Time High₹4,547.80 (Jul 03, 2023)₹875.00 (Apr 24, 2006)
% from All-Time High-99.99%-75.68%
Growth Metrics
Quarterly Revenue Growth3.43%-0.43%
Quarterly Earnings Growth3.86%-0.43%
Financial Health
Profit Margin (TTM) i0.02%-0.53%
Operating Margin (TTM) i0.07%-7.01%
Return on Equity (TTM) i0.16%1.58%
Debt to Equity (MRQ) i1,033.81-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹1.19₹-10.63
Cash per Share (MRQ)₹0.02₹0.03
Operating Cash Flow (TTM) i₹-9,983,884,288₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹-9,656,687,616₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Remedium Lifecare Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricREMLIFE (Mar 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i6.54-13.65
Forward P/E iN/A2.60
PEG Ratio i0.03-11.15
Price to Sales (TTM) i0.1487.98
Price to Book (MRQ) i0.71-13.55
Market Capitalization
Market Capitalization i₹308.70M₹46.75B
Enterprise Value i₹11.62B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i2.2195.73
Enterprise to EBITDA i206.57-22.27
Risk & Other Metrics
Beta i1.040.19
Book Value per Share (MRQ) i₹1.19₹-10.63

Financial Statements Comparison: Remedium Lifecare Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricREMLIFE (2025)SPARC (2025)
Revenue/Sales i4.05B717.66M
Cost of Goods Sold i3.98B1.10B
COGS % of Revenue i98.2%153.2%
Gross Profit i71.16M-381.94M
Gross Margin i1.8%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i12.30M-3.34B
Operating Margin i0.3%-465.5%
EBITDA i120.41M-3.23B
EBITDA Margin i3.0%-450.0%
Pre-Tax Income i43.84M-3.43B
Pre-Tax Income % of Revenue i1.1%-477.6%
Income Tax i22.55M-2.72M
Income Tax % of Revenue i0.6%-0.4%
Net Income (Profit) i21.29M-3.43B
Profit Margin i0.5%-477.3%

Balance Sheet & Liquidity Metrics

MetricREMLIFE (2025)SPARC (2025)
Cash & Equivalents i2.82M19.64M
Total Current Assets i17.20B261.97M
Total Current Assets % of Revenue i424.5%36.5%
Total Current Liabilities i16.76B3.74B
Total Current Liabilities % of Revenue i413.7%521.5%
Long-Term Debt i01.07B
Long-Term Debt % of Revenue i0.0%149.0%
Total Shareholders Equity i438.91M-2.17B
Retained Earnings i35.71M-23.22B
Retained Earnings % of Revenue i0.9%-3,235.0%
Property, Plant & Equipment i83,000178.02M

Cash Flow Statement Comparison

MetricREMLIFE (2025)SPARC (2025)
Operating Cash Flow i-16.38B-3.48B
Operating Cash Flow % of Revenue i-404.2%-485.5%
Capital Expenditures iN/A-97.45M
Free Cash Flow i-11.44B-3.71B
FCF Margin i-282.4%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricREMLIFESPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i881.99M324.52M
Float Shares i382.00M91.32M
% Held by Insiders i15.76%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i84.24%24.48%

Dividend Analysis & Yield Comparison: Remedium Lifecare Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricREMLIFESPARC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A